Source: European Parliament
This briefing provides a legal analysis and critical assessment of the genetically modified micro-organisms (GMM) component of the Commission proposal for a Directive amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs. This proposal was presented in December 2025 and accompanies the European Biotech Act. The briefing presents and analyses the proposed GMM-related amendments, situates the proposal within the international legal context and the wider EU secondary legal framework, and discusses potential benefits, risks and strategic considerations.
